Literature DB >> 27019989

Mass Media Intervention in Western Norway Aimed at Improving Public Recognition of Stroke, Emergency Response, and Acute Treatment.

Rajiv Advani1, Halvor Naess2, Martin Kurz3.   

Abstract

BACKGROUND: This study evaluates the effect of a mass media intervention (MMI) on the number of admissions to the emergency room (ER) with a suspected acute-onset stroke and on the number of patients treated with intravenous thrombolysis (IVT). The MMI was run for 1 month, with a precampaign month, priming the treatment chain and raising in-hospital awareness.
METHODS: This study conducted a prospective analysis of all patients admitted to the ER before, during, and after the MMI to assess changes in admission rate and IVT treatment rate. The primary end point was to assess any change in the IVT treatment rate, and the secondary end point was to determine the number of acute stroke admissions to the ER within 4.5 hours of symptom onset.
RESULTS: The MMI resulted in an increased IVT treatment rate from 7.3 to 11.3 patients per month, an increment of 54% (P = .002). This also resulted in IVT treatment percentages as high as 42%. The number of suspected acute stroke admissions to the ER increased from 37.3 to 72.8 patients per month, a 97% increase (P < .0001). The Epinion interviews showed that stroke symptom recognition increased from 66% to 75%.
CONCLUSION: The MMI produced a significant increase in IVT treatment rate. This increased treatment rate is largely due to the increase in the number of acute stroke admissions to the ER. Targeting the treatment chain before the MMI led to unprecedented IVT treatment percentages. The effect of our MMI lasted for approximately 6 months before tapering off; repeated campaigns are a prerequisite for sustained IVT treatment rates.
Copyright © 2016 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IVT; Stroke; acute treatment; awareness campaign; thrombolysis; treatment rates

Mesh:

Year:  2016        PMID: 27019989     DOI: 10.1016/j.jstrokecerebrovasdis.2016.02.026

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  7 in total

1.  Determinants of Treatment Modification in Hypercholesterolemic Patients.

Authors:  Ko-Fan Wang; Cheng-Hsueh Wu; Chun-Chin Chang; Lung-Ching Chen; Kang-Ling Wang; Tse-Min Lu; Shing-Jong Lin; Chern-En Chiang
Journal:  Acta Cardiol Sin       Date:  2017-03       Impact factor: 2.672

Review 2.  Knowledge, Prevention Practice and Associated Factors of Stroke Among Hypertensive and Diabetic Patients - A Systematic Review.

Authors:  Abreham Degu Melak; Dawit Wondimsigegn; Zemene Demelash Kifle
Journal:  Risk Manag Healthc Policy       Date:  2021-08-11

3.  The golden hour of acute ischemic stroke.

Authors:  Rajiv Advani; Halvor Naess; Martin W Kurz
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2017-05-22       Impact factor: 2.953

4.  Complementary and alternative medicine use among outpatients during the 2015 MERS outbreak in South Korea: a cross-sectional study.

Authors:  Jung Hye Hwang; Hyun Jeong Cho; Hyea Bin Im; Young Sun Jung; Soo Jeung Choi; Dongwoon Han
Journal:  BMC Complement Med Ther       Date:  2020-05-13

5.  Fewer ischemic strokes, despite an ageing population: stroke models from observed incidence in Norway 2010-2015.

Authors:  Kim Rand; Fredrik Andreas Dahl; Joe Viana; Ole Morten Rønning; Kashif Waqar Faiz; Mathias Barra
Journal:  BMC Health Serv Res       Date:  2019-10-16       Impact factor: 2.655

6.  Stroke prevention and therapy awareness in a large sample of high school students: results of an educational campaign in the Northern-Western Italy.

Authors:  Carlo Gandolfo; Francesco Alberti; Massimo Del Sette; Nicoletta Reale
Journal:  Neurol Sci       Date:  2022-09-10       Impact factor: 3.830

7.  Stroke incidence in the young: evidence from a Norwegian register study.

Authors:  Mathias Barra; Angela S Labberton; Kashif W Faiz; Jonas C Lindstrøm; Ole Morten Rønning; Joe Viana; Fredrik A Dahl; Kim Rand
Journal:  J Neurol       Date:  2018-10-30       Impact factor: 4.849

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.